× Digital News Videos Health & Science Opinion Education Columnists Lifestyle Cartoons Moi Cabinets Kibaki Cabinets Arts & Culture Podcasts E-Paper Tributes Lifestyle & Entertainment Nairobian Entertainment Eve Woman TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
×

Britain secures 60 million doses of Sanofi/GSK Covid-19 vaccine

EUROPE

With more than 20 vaccines in human trials, the move will stir concerns that rich countries, including the United States and European Union members

Britain secures 60 million doses of Sanofi/GSK Covid-19 vaccine

By Reuters | 11 months ago

GSK cuts prices of drugs to up healthcare in Kenya

GSK cuts prices of drugs to up healthcare in Kenya

Leading pharmaceutical manufacturing company, GlaxoSmithKline, has cut of prices of its key essential drugs by about 50 per cent to improve access.

| 10 years ago

Pharmaceutical firm reduces prices of key antibiotics

Pharmaceutical firm GlaxoSmithKline has announced a price reduction of between 30 to 40 per cent of its key antibiotics, Zinnat and Augmentin across East Africa.

| 11 years ago

Battle to control energy drinks market

John Makumbi, a 35-year old sales executive with a leading transport firm says he will drink anything with the word "energy" on the can. Last year, he started taking an energy drink every mornings. At first, Makumbi was sceptical it would actually give him more energy. "I'm pumped or something. I'm awake. It's a good feeling," says Makumbi as he struggles to explain how this energy drink makes him feel.

| 12 years ago

Feedback